Top news
NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19
Fauci says leak concerns fueled his White House revelation of Gilead drug results
By Julie Steenhuysen
Gilead's remdesivir shows some benefit in early results as coronavirus treatment - The Washington Post
By Laurie McGinley & Christopher Rowland
All coverage
FDA issues emergency-use authorization for remdesivir in hospitalized coronavirus patients in severe condition
By Arman Azad & Nicole Chavez
Remdesivir Shows Modest Benefits in Coronavirus Trial
By Gina Kolata, Peter Baker & Noah Mercer Weiland
Dr. Anthony Fauci says Gilead's remdesivir will set a new 'standard of care' for coronavirus treatment
By Berkeley Lovelace & Berkeley Lovelace Jr.
Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work?
By Melissa Davey
Researchers changed criteria for assessing Gilead’s drug remdesivir in coronavirus treatment trials
By Christopher Rowland
Critical study of Gilead's Covid-19 drug shows patients are responding to treatment, NIH says
By Matthew Herper & Adam Feuerstein